These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 33859644)

  • 1. Innate and Adaptive Immunity Alterations in Metabolic Associated Fatty Liver Disease and Its Implication in COVID-19 Severity.
    Lamadrid P; Alonso-Peña M; San Segundo D; Arias-Loste M; Crespo J; Lopez-Hoyos M
    Front Immunol; 2021; 12():651728. PubMed ID: 33859644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical implications of COVID-19 in patients with metabolic-associated fatty liver disease.
    Jeeyavudeen MS; Chaudhari R; Pappachan JM; Fouda S
    World J Gastroenterol; 2023 Jan; 29(3):487-502. PubMed ID: 36688018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic dysfunction associated fatty liver disease and coronavirus disease 2019: clinical relationship and current management.
    Xu Y; Yang X; Bian H; Xia M
    Lipids Health Dis; 2021 Oct; 20(1):126. PubMed ID: 34602072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immune response to SARS-CoV-2 and COVID-19 immunopathology - Current perspectives.
    Boechat JL; Chora I; Morais A; Delgado L
    Pulmonology; 2021; 27(5):423-437. PubMed ID: 33867315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How kids' immune systems can evade COVID.
    Nogrady B
    Nature; 2020 Dec; 588(7838):382. PubMed ID: 33303982
    [No Abstract]   [Full Text] [Related]  

  • 6. Association and Interaction Between Serum Interleukin-6 Levels and Metabolic Dysfunction-Associated Fatty Liver Disease in Patients With Severe Coronavirus Disease 2019.
    Gao F; Zheng KI; Yan HD; Sun QF; Pan KH; Wang TY; Chen YP; Targher G; Byrne CD; George J; Zheng MH
    Front Endocrinol (Lausanne); 2021; 12():604100. PubMed ID: 33763027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex-based differences in severity and mortality in COVID-19.
    Alwani M; Yassin A; Al-Zoubi RM; Aboumarzouk OM; Nettleship J; Kelly D; Al-Qudimat AR; Shabsigh R
    Rev Med Virol; 2021 Nov; 31(6):e2223. PubMed ID: 33646622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperinflammation and Immune Response Generation in COVID-19.
    Mishra KP; Singh AK; Singh SB
    Neuroimmunomodulation; 2020; 27(2):80-86. PubMed ID: 33341814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of SARS-CoV-2 infection in the setting of the cytokine release syndrome.
    Azar MM; Shin JJ; Kang I; Landry M
    Expert Rev Mol Diagn; 2020 Nov; 20(11):1087-1097. PubMed ID: 32990479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune profiling of COVID-19: preliminary findings and implications for the pandemic.
    Maecker HT
    J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 33963016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review on the immune responses against novel emerging coronavirus (SARS-CoV-2).
    Lotfi R; Kalmarzi RN; Roghani SA
    Immunol Res; 2021 Jun; 69(3):213-224. PubMed ID: 33928531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MAFLD in COVID-19 patients: an insidious enemy.
    Dongiovanni P; Meroni M; Longo M; Fracanzani AL
    Expert Rev Gastroenterol Hepatol; 2020 Oct; 14(10):867-872. PubMed ID: 32705906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronavirus disease 2019 severity in obesity: Metabolic dysfunction-associated fatty liver disease in the spotlight.
    Vasques-Monteiro IML; Souza-Mello V
    World J Gastroenterol; 2021 Apr; 27(16):1738-1750. PubMed ID: 33967554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysregulated Innate and Adaptive Immune Responses Discriminate Disease Severity in COVID-19.
    Janssen NAF; Grondman I; de Nooijer AH; Boahen CK; Koeken VACM; Matzaraki V; Kumar V; He X; Kox M; Koenen HJPM; Smeets RL; Joosten I; Brüggemann RJM; Kouijzer IJE; van der Hoeven HG; Schouten JA; Frenzel T; Reijers MHE; Hoefsloot W; Dofferhoff ASM; van Apeldoorn MJ; Blaauw MJT; Veerman K; Maas C; Schoneveld AH; Hoefer IE; Derde LPG; van Deuren M; van der Meer JWM; van Crevel R; Giamarellos-Bourboulis EJ; Joosten LAB; van den Heuvel MM; Hoogerwerf J; de Mast Q; Pickkers P; Netea MG; van de Veerdonk FL
    J Infect Dis; 2021 Apr; 223(8):1322-1333. PubMed ID: 33524124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profiling of immune dysfunction in COVID-19 patients allows early prediction of disease progression.
    Rendeiro AF; Casano J; Vorkas CK; Singh H; Morales A; DeSimone RA; Ellsworth GB; Soave R; Kapadia SN; Saito K; Brown CD; Hsu J; Kyriakides C; Chiu S; Cappelli LV; Cacciapuoti MT; Tam W; Galluzzi L; Simonson PD; Elemento O; Salvatore M; Inghirami G
    Life Sci Alliance; 2021 Feb; 4(2):. PubMed ID: 33361110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How could we forget immunometabolism in SARS-CoV2 infection or COVID-19?
    Kumar V
    Int Rev Immunol; 2021; 40(1-2):72-107. PubMed ID: 33155525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic SARS-CoV-2-Specific Immunity in Critically Ill Patients With Hypertension.
    Zeng Q; Li YZ; Dong SY; Chen ZT; Gao XY; Zhang H; Huang G; Xu Y
    Front Immunol; 2020; 11():596684. PubMed ID: 33362779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical perspectives, assessment, and mechanisms of metabolic-associated fatty liver disease in patients with COVID-19.
    Campos-Murguía A; Román-Calleja BM; González-Regueiro JA; Hurtado-Díaz-de-León I; Solís-Ortega AA; Flores-García NC; García-Juárez I; Ruiz-Margáin A; Macías-Rodríguez RU
    World J Gastroenterol; 2021 Sep; 27(33):5502-5519. PubMed ID: 34588748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The laboratory tests and host immunity of COVID-19 patients with different severity of illness.
    Wang F; Hou H; Luo Y; Tang G; Wu S; Huang M; Liu W; Zhu Y; Lin Q; Mao L; Fang M; Zhang H; Sun Z
    JCI Insight; 2020 May; 5(10):. PubMed ID: 32324595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Diabetes in Patients Diagnosed With COVID-19.
    Abu-Farha M; Al-Mulla F; Thanaraj TA; Kavalakatt S; Ali H; Abdul Ghani M; Abubaker J
    Front Immunol; 2020; 11():576818. PubMed ID: 33335527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.